Table 2. S-bFGF and the Components of... | American Society of Hematology

Table 2.

S-bFGF and the Components of the IPI in Multivariate Analyses

Factor	P	β	SE	RR (e^β)	95% CI for RR
WHO performance status
0-1v 2-4	<.0001	1.21	0.29	3.35	1.92-5.87
Continuous	<.0001
Age at diagnosis (yr)
≤60v >60	<.0001	1.02	0.25	2.79	1.14-4.58
Continuous	.0009
Ann Arbor stage
I-IIv III-IV	.0019	0.80	0.26	2.23	1.33-3.72
Continuous	.0028
S-bFGF at diagnosis
<5.5v ≥5.5 pg/mL (the highest quartile)	.0079	0.70	0.27	2.02	1.20-3.42
Continuous	.024
Serum LDH at diagnosis
Normal v abnormal	.014	0.65	0.27	1.92	1.14-3.25
Continuous	.74
No. of extranodal tumor sites
≤1 v >1	.039	0.71	0.35	2.04	1.04-4.01
Continuous	.35

Factor	P	β	SE	RR (e^β)	95% CI for RR
WHO performance status
0-1v 2-4	<.0001	1.21	0.29	3.35	1.92-5.87
Continuous	<.0001
Age at diagnosis (yr)
≤60v >60	<.0001	1.02	0.25	2.79	1.14-4.58
Continuous	.0009
Ann Arbor stage
I-IIv III-IV	.0019	0.80	0.26	2.23	1.33-3.72
Continuous	.0028
S-bFGF at diagnosis
<5.5v ≥5.5 pg/mL (the highest quartile)	.0079	0.70	0.27	2.02	1.20-3.42
Continuous	.024
Serum LDH at diagnosis
Normal v abnormal	.014	0.65	0.27	1.92	1.14-3.25
Continuous	.74
No. of extranodal tumor sites
≤1 v >1	.039	0.71	0.35	2.04	1.04-4.01
Continuous	.35

Abbreviations: β, estimated coefficient of the hazard function; SE, standard error; RR, relative risk.